Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4405 results

Sort By:

Gemcitabine/Cisplatin/Nab-Paclitaxel and Rilvegostomig in Resectable iCCA

Study ID: NCT06569225
Start Date: 2024-12-15
End Date: 2028-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

40

Intervention / Treatment

Gemcitabine/Cisplatin/Nab-Paclitaxel and Rilvegostomig

Sponsor

University Health Network, Toronto

Source: clinicaltrials.gov

Share:
Add to list

PrediSuisse: Automatized Assessment of Difficult Airway

Study ID: NCT06453525
Start Date: 2024-12-01
End Date: 2027-01-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1800

Intervention / Treatment

intubation

Sponsor

Vaudois University Hospital Center

Source: clinicaltrials.gov

Share:
Add to list

Nudging to Promote the Use of Transcutaneous Electrical Nerve Stimulation for Postoperative Pain Relief

Study ID: NCT06696430
Start Date: 2024-12-09
End Date: 2025-05-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

500

Intervention / Treatment

Educational Intervention on TENS Usage

Nudging Intervention to Promote TENS Usage

Sponsor

Pether Jildenstal

Source: clinicaltrials.gov

Share:
Add to list

Adding Urea to the Final Dialysis Fluid

Study ID: NCT06366230
Start Date: 2025-07-01
End Date: 2028-06-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

20

Intervention / Treatment

Urea in the dialysate

Sponsor

University of California, San Francisco

Source: clinicaltrials.gov

Share:
Add to list

Personalized NFTs As a Trial Participation Incentive

Study ID: NCT06647030
Start Date: 2025-01-02
End Date: 2025-06-02
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

15

Intervention / Treatment

CURATE.DTx sessions

Interview

Sponsor

Institute for Digital Medicine (WisDM)

Source: clinicaltrials.gov

Share:
Add to list

A Phase 2 Study of NEU-411 in Companion Diagnostic-Positive Participants with Early Parkinson's Disease

Study ID: NCT06680830
Start Date: 2025-01
End Date: 2027-09
Study Type

Interventional

Study Phase

Phase2

No. of Participants

150

Intervention / Treatment

NEU-411

Placebo

Sponsor

Neuron23 Inc.

Source: clinicaltrials.gov

Share:
Add to list

Conventional Vestibular Training Versus Immersive Virtual Reality- Based Vestibular in Multiple Sclerosis

Study ID: NCT04497025
Start Date: 2026-01
End Date: 2029-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Immersive Virtual-based vestibular rehabilitation

Conventional vestibular rehabilitation protocol

Sponsor

Maria Jesus Casuso-Holgado

Source: clinicaltrials.gov

Share:
Add to list

Risk Factors of Mortality in Neonatal Pneumonia

Study ID: NCT06599125
Start Date: 2025-01-01
End Date: 2025-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

85

Intervention / Treatment
Sponsor

Assiut University

Source: clinicaltrials.gov

Share:
Add to list

Post-marketing Surveillance Study for the Safety of Efluelda Tetra Pre-filled Syringe.

Study ID: NCT06694025
Start Date: 2024-11-22
End Date: 2030-12-05
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

670

Intervention / Treatment

Efluelda Tetra Pre-filled syringe

Sponsor

Sanofi

Source: clinicaltrials.gov

Share:
Add to list

Technology in Play for Children With Physical Disabilities: the Dice Model of Play

Study ID: NCT06319430
Start Date: 2024-12-01
End Date: 2026-05-28
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

10

Intervention / Treatment

robots

conventional

Sponsor

University of Manitoba

Source: clinicaltrials.gov

Share:
Add to list